Generic placeholder image

The Natural Products Journal

Editor-in-Chief

ISSN (Print): 2210-3155
ISSN (Online): 2210-3163

Research Article

In Silico Identification of Natural Lead Molecules from the Genus of Phyllanthus Against Hepatitis B Virus Reverse Transcriptase

Author(s): Kishore Sarma, Biswajyoti Borkakoty, Pratap Parida, Aniruddha Jakharia, Dipankar Dey, Dipankar Biswas, Debashis Panda, Mahendra K. Modi, Pradyumna K. Mohapatra and Jagadish Mahanta

Volume 6, Issue 4, 2016

Page: [292 - 304] Pages: 13

DOI: 10.2174/2210315506666160822095818

Price: $65

Abstract

Background: Hepatitis B virus claims approximately 780000 human lives each year. Inadequate effectiveness and drug resistance has led to the search for more potent antivirals with minimal risk of resistance. Plant extract from Phyllanthus genus have long been used in traditional medicine as effective antiviral and hepatoprotective agents.

Objective: The present study aims to find the active principle of Phyllanthus and their mode of action against Hepatitis B Virus Reverse Transcriptase (HBV RT), a potential drug target of HBV infection.

Methods: The 3D structure of HBV RT was modeled and its stability was assessed with a 50ns molecular dynamics simulation. Ninety-three phytochemicals were screened from Phyllanthus and used for docking study taking lamivudine as control drug.

Results: Comparison of binding energy suggests that, lupeol acetate, a triterpene of P. niruri, P. reticulatus and P. urinaria showed highest binding energy for both native and M204V mutated HBV RT (-7.95 kcal/mol & -6.16 kcal/mol respectively) than the control drug lamivudine (-4.57 kcal/mol & -3.50 kcal/mol respectively). Subsequently, lupeol acetate was screened for in silico ADME/Tox property and result indicates good bioavailability without toxicity and can be treated as a candidate drug molecule.

Conclusion: Further clinical testing may lead to the discovery of a novel HBV RT inhibitor.

Keywords: Phyllanthus, lupeol acetate, Hepatitis B virus, molecular docking, molecular dynamics simulation, in silico ADME/Tox and Lamivudine.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy